Clinical Research Trials
Retinal diseases are a leading cause of vision loss and blindness, affecting millions of people worldwide. Clinical trials are vital to the development of new treatments and therapies for these conditions, and there are many ongoing trials testing promising new approaches.
Star Retina is proud to take part in clinical research trials for many common retinal conditions. Below are trials for which we are currently enrolling new patients and those that have been completed.
Wet AMD / Neovascular AMD
-
Artemis CurrentAdverum | ADVM-022-12Method: Suprachoroidal eye injection
-
Lucia CurrentEyePoint | EYP-1901-302Method: Intravitreal implant + eye injection
-
Daybreak CurrentKodiak | KS301P109Method: Intravitreal eye injection
-
SOL-1 CurrentOcular Therapeutix | OTX-TKI-2023-AMD-301Method: Intravitreal implant + eye injection
-
SOL-R CurrentOcular Therapeutix | OTX-TKI-2023-AMD-303Method: Intravitreal implant + eye injection
-
Achieve CurrentAbbVie | M24-528Method: Suprachoroidal eye injectionHistory: Experienced
-
Atmosphere CurrentAbbVie | RGX-314-2104History: Experienced
-
Ascent CurrentAbbVie | RGX-314-3101History: Experienced
-
Crossover CurrentAbbVie | RGX-314-5101
-
NOVA1 CurrentAlcon | RTE888-E001Method: Intravitreal implant
-
STAT UpcomingSyneos | ocul101-002Method: Intravitreal eye injection
-
SOL-X UpcomingOcular Therapeutix | OTX-TKI-2025-AMD-301Method: Intravitreal eye injection
-
SAHARA UpcomingOllin Biosciences | OLN324-CP-05Method: Intravitreal eye injection
Diabetic Macular Edema (DME)
-
Barolo CurrentEyeBio | EYE-RES-103Method: Intravitreal eye injection
-
ATACAMA UpcomingOllin Biosciences | OLN324-CP-02Method: Intravitreal eye injection
-
BI 1485-0018 UpcomingIQVIA | BI 1485-0018Method: Oral medication
-
NAAVIGATE UpcomingAbbVie | M23-415Method: Suprachoroidal eye injection
-
SYRAH*** UpcomingMerck & Co | MK-8748-005Method: Intravitreal eye injection
-
Diamond 2 CompletedOculis | DX221
Retinal Vein Occlusion / Multi-Indication
-
Kalaris CurrentKalaris Therapeutics | KLRS-100Method: Intravitreal eye injectionHistory: Naive arm
-
Kalaris UpcomingKalaris Therapeutics | KLRS-100Method: Intravitreal eye injectionHistory: Naive arm
-
Super Tuscan CompletedEyeBio | EYE-RES-104Method: Intravitreal eye injection
Retinal Vein Occlusion
-
MK-8748-006 UpcomingMerck & Co | MK-8748-006Method: Intravitreal eye injection
Geographic Atrophy / Dry AMD
-
Journey CurrentPerceive Bio | PBI-AMD-002Method: Intravitreal eye injection
-
Sahara CurrentOllin Biosciences | OLN324-CP-05
-
Sienna CurrentRegeneron | R3918-AMD-2326
-
Sitala Bio CurrentIQVIA Biotech | STL303-202Method: Oral medication
-
Astellas UpcomingAstellas Institute for Regenerative Medicine (AIRM) | 7317-CL-0008Method: Subretinal surgical injection
-
Genentech UpcomingGenentech, Inc. | XR46785Method: Intravitreal eye injection
-
7317-CL-0009 UpcomingAstellas Pharma | 7317-CL-0009
-
CTX114-CS201 UpcomingSyneos | CTX114-CS201Method: Intravitreal eye injection
-
CTX203-CS201 UpcomingCTX203-CS201Method: Intravitreal eye injection
-
ReBuild UpcomingMighty Therapeutics | MYTX272AM-201Method: Eye drops
-
Sitala UpcomingSitala Bio | STL303-202Method: Oral medication
-
Nirvana CompletedPerceive Bio | PBI-AMD-NH1
Diabetic Retinopathy (DR)
-
HELIOS-3 CurrentOcular Therapeutix | OTX-TKI-2025-NPDR-302Method: Intravitreal implant + eye injection
-
Altitude CurrentAbbVie | RGX-314-2202
-
NAAVIGATE CurrentAbbVie | M23-415
-
LTFU CurrentAbbVie | RGX-314-5201
-
AP UpcomingDRCR
-
Helios-3 UpcomingOcular Therapeutix | OTX-TKI-2025-NPDR-302Method: Intravitreal implant
-
Glow2 CompletedKodiak | KS301P108Method: Intravitreal eye injection
Other / Not Specified
-
Hunter UpcomingAstellas Pharma | 3021-CL-3003
-
AM UpcomingDRCR
-
LTFU UpcomingAbbVie | RGX-314-5201
Stargardt Disease
-
NORTHSTAR CurrentAlkeus Pharmaceuticals | ALK001-P1004Method: Oral medication
Trial availability and eligibility change often. Please call our office at 817-378-4777 to confirm whether a study is right for you or your patient.
